nhia logo

Quick Links
Search NHIA.org



Alborghetti M. Medical waste: No "throw-away" issue. 1999;5(12): 20-5.

Barrell JM. Corporate compliance starts with commitment. 1998;4(10):51-54.

Bing CM. Take a risk management checkup: A self-assessment for home infusion providers. 1997;4(1):41-5.

Bring J and McLeod C. How is a government investigation like an ultramarathon? What home infusion providers need to know before approaching the starting line. 2014;20(5):35-41.

Counce JB. DEHP in medical devices: Sleeping tiger or paper tiger. 2002;8(5):18-25.

Counce J and Prosser B. Practicing ethical decision-making in alternate-site infusion: A well-constructed ethical framework is the key to resolving ethical dilemmas in business operations and patient care. 2011;17(6):24-32.

Counce J and Grissinger M. Delving into the unknown unknowns: Using Failure Mode and Effects Analysis (FMEA) to root out risk in home and specialty infusion pharmacy. 2014;20(2):29-35.

Counce J. Medicare documentation: Best practices for reducing your risk of audit-related resource drain. 2014;20(2):18-26.

Counce J. ICD-10 implementation is back—and this time it's for real: Effective steps to minimize the risk of cash flow disruptions. 2015;21(2):21-25.

Cohen H, Proulx S. Preventing medication errors in home care. 1998;4(6):46-52.

Dillon R. Applying risk management techniques used in medical device manufacturing to home infusion. 2009:15(2);52-55.

Dobies C. Outcomes programs: They're not just for JACHO anymore. 1998;4(11):30-33.

Epperson LA and Williams J. Biotherapy: Operationalizing delivery of care while managing risk. 2009:15(2);23-9.

Heagy K and Kramer N. Crossing the Cultural Divide—Cultural Competence is Critical to Safe and Effective Health Care. 2010:16(3);32-7.

Kastango E and Kramer N. The Top 10 Things You Need to Know About USP <797>. 2009:15(3);43-8.

Kramer N and Counce J. The significant seven: Things you might not know about employee and environmental health and safety regulations—but should. 2011; 17(4):21-27.

Leone M and Counce J. Medical marijuana: Implications for home infusion providers. 2010; 16(6):27-37.

McGarity GJ and Ariano RE. Gentamicin: The case for litigation prophylaxis. 2014;20(2):37-44.

Meaux N and Siefert L. Managing risk in the increasingly complex home care environment. 2009:15(2);36-40.

Pelissero PS. Interviewing job applicants: Asking the “right” questions without getting into legal hot water. 2003;9(5):18-21.

Rahn T. Patient safety in the home care setting: Tools for recognizing concerns and taking preemptive action. 2015;21(2):27-31.

Salvatore T, Baxter T. Beyond compliance: Building an ethical framework for your organization. 1998;5(2):39-42.

Stranz M. Aminoglycoside therapy in the home: Side effects, risk management, and effective care coordination.2008:14(1);29-34.

Stribling C. Managing risk with corporate compliance programs.200713(2);25-8.

Sullivan K, Schnell D. Needleless systems. 1994;1(1):17-19.

Sullivan C. If you do it, document it: The many benefits of examining and improving clinical documentation practices. 2009:15(1);27-33.

Tharp J. Strategies for proactively managing the risk points associated with drug shortages. 2015;21(2):32-44.